|
US5470571A
(en)
|
1988-01-27 |
1995-11-28 |
The Wistar Institute |
Method of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425
|
|
FR2660556B1
(fr)
|
1990-04-06 |
1994-09-16 |
Rhone Poulenc Sante |
Microspheres, leur procede de preparation et leur utilisation.
|
|
IL98528A0
(en)
|
1990-06-21 |
1992-07-15 |
Merck & Co Inc |
Pharmaceutical compositions containing hybrid for killing bladder cancer cells
|
|
ATE247168T1
(de)
|
1991-03-06 |
2003-08-15 |
Merck Patent Gmbh |
Humanisierte monoklonale antikörper
|
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
CA2086874E
(en)
|
1992-08-03 |
2000-01-04 |
Renzo Mauro Canetta |
Methods for administration of taxol
|
|
US6306421B1
(en)
|
1992-09-25 |
2001-10-23 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5362478A
(en)
|
1993-03-26 |
1994-11-08 |
Vivorx Pharmaceuticals, Inc. |
Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
|
|
CN1245156C
(zh)
|
1993-02-22 |
2006-03-15 |
美国生物科学有限公司 |
用于体内传送生物制品的方法及用于该方法的组合物
|
|
US20030068362A1
(en)
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
|
US6528067B1
(en)
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US5650156A
(en)
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030133955A1
(en)
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5665383A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of immunostimulating agents for in vivo delivery
|
|
US5997904A
(en)
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US5665382A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
PT1155689E
(pt)
|
1993-07-19 |
2007-01-31 |
Angiotech Pharm Inc |
Composições anti-angiogenicas e metodos de utilização
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
US6441026B1
(en)
|
1993-11-08 |
2002-08-27 |
Aventis Pharma S.A. |
Antitumor compositions containing taxane derivatives
|
|
AU1831395A
(en)
|
1994-01-14 |
1995-08-01 |
Cell Therapeutics, Inc. |
Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf
|
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
|
US5662883A
(en)
|
1995-01-10 |
1997-09-02 |
Nanosystems L.L.C. |
Microprecipitation of micro-nanoparticulate pharmaceutical agents
|
|
US5534270A
(en)
|
1995-02-09 |
1996-07-09 |
Nanosystems Llc |
Method of preparing stable drug nanoparticles
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
US5609629A
(en)
|
1995-06-07 |
1997-03-11 |
Med Institute, Inc. |
Coated implantable medical device
|
|
CA2178541C
(en)
|
1995-06-07 |
2009-11-24 |
Neal E. Fearnot |
Implantable medical device
|
|
US6565842B1
(en)
|
1995-06-07 |
2003-05-20 |
American Bioscience, Inc. |
Crosslinkable polypeptide compositions
|
|
US5744460A
(en)
|
1996-03-07 |
1998-04-28 |
Novartis Corporation |
Combination for treatment of proliferative diseases
|
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
|
EP0932399B1
(en)
|
1996-03-12 |
2006-01-04 |
PG-TXL Company, L.P. |
Water soluble paclitaxel prodrugs
|
|
ATE222502T1
(de)
|
1996-07-30 |
2002-09-15 |
Novartis Ag |
Kombinationspräparat mit hemmender wirkung auf die abstossung von transplantaten, autoimmunerkrankungen und entzündungen, welches cyclosporin a und 40-0-(2-hydroxyethyl)-rapamycin enthält
|
|
US20070092563A1
(en)
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
DK1325932T5
(da)
|
1997-04-07 |
2005-10-03 |
Genentech Inc |
Anti-VEGF antistoffer
|
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
CA2765222C
(en)
*
|
1997-06-27 |
2017-05-09 |
Abraxis Bioscience, Llc |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030199425A1
(en)
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
DK1023050T3
(da)
|
1997-06-27 |
2013-10-14 |
Abraxis Bioscience Llc |
Nye formuleringer af farmakologiske midler, fremgangsmåder til fremstillingen deraf og fremgangsmåder til anvendelsen deraf
|
|
US6258084B1
(en)
|
1997-09-11 |
2001-07-10 |
Vnus Medical Technologies, Inc. |
Method for applying energy to biological tissue including the use of tumescent tissue compression
|
|
GB9800569D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
|
ES2279614T3
(es)
|
1998-04-16 |
2007-08-16 |
Eurovita A/S |
Nuevas composiciones sinergicas que contienen compuestos aromaticos y terpenoides presentes en alpinia galanga.
|
|
IL141155A0
(en)
|
1998-07-30 |
2002-02-10 |
Human Rt |
Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin
|
|
US6682758B1
(en)
|
1998-12-22 |
2004-01-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water-insoluble drug delivery system
|
|
US6537585B1
(en)
|
1999-03-26 |
2003-03-25 |
Guilford Pharmaceuticals, Inc. |
Methods and compositions for treating solid tumors
|
|
AU777528B2
(en)
|
1999-04-22 |
2004-10-21 |
Abraxis Bioscience, Llc |
Long term administration of pharmacologically active agents
|
|
HK1045646A1
(zh)
|
1999-05-21 |
2002-12-06 |
Abraxis Bioscience, Llc |
蛋白質穩定化的藥理學活性劑，其製備方法及其使用方法
|
|
AU5273200A
(en)
|
1999-05-24 |
2000-12-12 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
EP1267913A2
(en)
|
1999-11-12 |
2003-01-02 |
EntreMed, Inc. |
Methods for administration of therapeutic agents on an antiangiogenic schedule
|
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
|
US20020041888A1
(en)
|
2000-04-10 |
2002-04-11 |
Moshe Flashner-Barak |
Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
|
|
ITMI20001107A1
(it)
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
|
CZ300945B6
(cs)
|
2000-06-30 |
2009-09-23 |
Glaxo Group Limited |
Zpusob prípravy 5-(6-chinazolinyl)-furan-2-karbaldehydu
|
|
AU2001292548B2
(en)
|
2000-07-28 |
2005-06-16 |
Sloan-Kettering Institute For Cancer Research |
Methods for treating cell proliferative disorders and viral infections
|
|
AU2001288805A1
(en)
|
2000-09-22 |
2002-04-02 |
Bristol-Myers Squibb Company |
Method for reducing toxicity of combined chemotherapies
|
|
ATE290882T1
(de)
|
2001-01-16 |
2005-04-15 |
Glaxo Group Ltd |
Pharmazeutische mischung gegen krebs, die ein 4- chinazolinamin in kombination mit paclitaxel, carboplatin or vinorelbine enthält
|
|
US6548531B2
(en)
|
2001-02-09 |
2003-04-15 |
Hoffmann-La Roche Inc. |
Method for cancer therapy
|
|
GB0103668D0
(en)
|
2001-02-15 |
2001-03-28 |
Biointeractions Ltd |
Methods and clinical devices for the inhibition or prevention of mammalian cell growth
|
|
WO2002069949A2
(en)
|
2001-03-06 |
2002-09-12 |
Prendergast Patrick T |
Combination therapy for reduction of toxycity of chemotherapeutic agents
|
|
RU2284184C2
(ru)
|
2001-03-06 |
2006-09-27 |
Бристол-Маерс Сквибб Компани |
Способ лечения рака
|
|
US6752922B2
(en)
|
2001-04-06 |
2004-06-22 |
Fluidigm Corporation |
Microfluidic chromatography
|
|
US7638161B2
(en)
|
2001-07-20 |
2009-12-29 |
Applied Materials, Inc. |
Method and apparatus for controlling dopant concentration during BPSG film deposition to reduce nitride consumption
|
|
US6872715B2
(en)
|
2001-08-06 |
2005-03-29 |
Kosan Biosciences, Inc. |
Benzoquinone ansamycins
|
|
US7056338B2
(en)
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
|
US20040033271A1
(en)
|
2001-12-03 |
2004-02-19 |
Seth Lederman |
Methods for contemporaneous administration of levamisole and 5-fluorouracil
|
|
US20040143004A1
(en)
|
2002-02-26 |
2004-07-22 |
Joseph Fargnoli |
Metronomic dosing of taxanes
|
|
ITMI20020681A1
(it)
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina
|
|
ITMI20020680A1
(it)
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento
|
|
US20040126400A1
(en)
|
2002-05-03 |
2004-07-01 |
Iversen Patrick L. |
Delivery of therapeutic compounds via microparticles or microbubbles
|
|
US20050276812A1
(en)
|
2004-06-01 |
2005-12-15 |
Genentech, Inc. |
Antibody-drug conjugates and methods
|
|
US7794743B2
(en)
|
2002-06-21 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of making the same
|
|
TWI272273B
(en)
|
2002-07-16 |
2007-02-01 |
Sonus Pharma Inc |
Platinum compounds
|
|
ATE502635T1
(de)
|
2002-08-19 |
2011-04-15 |
Pfizer |
Kombinationstherapie gegen hyperproliferative erkrankungen
|
|
US20040047835A1
(en)
|
2002-09-06 |
2004-03-11 |
Cell Therapeutics, Inc. |
Combinatorial drug therapy using polymer drug conjugates
|
|
US20050095267A1
(en)
|
2002-12-04 |
2005-05-05 |
Todd Campbell |
Nanoparticle-based controlled release polymer coatings for medical implants
|
|
SI1585548T1
(sl)
|
2002-12-09 |
2018-11-30 |
Abraxis Bioscience, Llc |
Sestave in metode odmerjanja farmakoloških sredstev
|
|
WO2004052401A2
(en)
|
2002-12-09 |
2004-06-24 |
American Bioscience, Inc. |
Compositions and methods of delivery of pharmacological agents
|
|
EP1587519A4
(en)
|
2003-01-10 |
2006-05-31 |
Threshold Pharmaceuticals Inc |
Treatment of cancer with 2-deoxyglucose
|
|
RU2005133199A
(ru)
|
2003-03-28 |
2006-02-10 |
Козан Байосайенсиз, Инк. (Us) |
Устройства, способы и композиции для предупреждения рестеноза
|
|
EP1643971A2
(en)
|
2003-05-22 |
2006-04-12 |
Neopharm, Inc. |
Liposomal formulations comprising a combination of two or more active agents
|
|
US20050026893A1
(en)
|
2003-05-30 |
2005-02-03 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants
|
|
MXPA05012723A
(es)
|
2003-05-30 |
2006-02-08 |
Genentech Inc |
Tratamiento con anticuerpos anti-vgf.
|
|
AR046510A1
(es)
|
2003-07-25 |
2005-12-14 |
Regeneron Pharma |
Composicion de un antagonista de vegf y un agente anti-proliferativo
|
|
JP2007505938A
(ja)
|
2003-09-23 |
2007-03-15 |
ノバルティス アクチエンゲゼルシャフト |
Ｖｅｇｆ受容体阻害剤と化学療法剤の組み合わせ
|
|
AU2004283464B8
(en)
|
2003-10-15 |
2011-04-14 |
Syncore Biotechnology Co., Ltd |
Method of administering cationic liposomes comprising an active drug
|
|
US7223770B2
(en)
|
2003-10-29 |
2007-05-29 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
US20080045559A1
(en)
|
2003-10-29 |
2008-02-21 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
US20050203174A1
(en)
|
2004-03-09 |
2005-09-15 |
Kosan Biosciences, Inc. |
Combination therapies using leptomycin B
|
|
WO2005090372A2
(en)
|
2004-03-15 |
2005-09-29 |
Sonus Pharmaceuticals, Inc. |
Platinum carboxylate anticancer compounds
|
|
US20060003931A1
(en)
|
2004-05-06 |
2006-01-05 |
Genentech, Inc. |
Crystal structure of the hepatocyte growth factor and methods of use
|
|
US8420603B2
(en)
|
2004-05-14 |
2013-04-16 |
Abraxis Bioscience, Llc |
SPARC and methods of use thereof
|
|
EP3327031A1
(en)
|
2004-05-14 |
2018-05-30 |
Abraxis BioScience, LLC |
Disease site-delivering pharmaceutical compositions comprising paclitaxel
|
|
AU2006249235B2
(en)
|
2004-05-14 |
2010-11-11 |
Abraxis Bioscience, Llc |
Sparc and methods of use thereof
|
|
MY194883A
(en)
|
2004-06-04 |
2022-12-21 |
Genentech Inc |
Method for treating multiple sclerosis
|
|
GT200500155A
(es)
|
2004-06-16 |
2006-05-15 |
|
Terapia del càncer resistente al platino
|
|
US8772269B2
(en)
|
2004-09-13 |
2014-07-08 |
Eisai R&D Management Co., Ltd. |
Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
|
|
US20070166388A1
(en)
|
2005-02-18 |
2007-07-19 |
Desai Neil P |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
WO2006112930A2
(en)
|
2005-02-18 |
2006-10-26 |
Abraxis Bioscience, Inc. |
Q3 sparc deletion mutant and uses thereof
|
|
CN103285395A
(zh)
*
|
2005-02-18 |
2013-09-11 |
阿布拉科斯生物科学有限公司 |
治疗剂的组合和给予方式以及联合治疗
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
WO2006091780A2
(en)
|
2005-02-24 |
2006-08-31 |
Elan Pharma International Limited |
Nanoparticulate formulations of docetaxel and analogues thereof
|
|
CN101232901B
(zh)
|
2005-02-28 |
2011-12-07 |
卫材R&D管理有限公司 |
磺酰胺化合物和血管生成抑制物质的联合新应用
|
|
EP1896007B1
(en)
|
2005-05-04 |
2014-03-19 |
Medigene AG |
Method of administering a cationic liposomal preparation comprising paclitexel
|
|
US20080221135A1
(en)
|
2005-05-13 |
2008-09-11 |
Bristol-Myers Squibb Company |
Combination therapy
|
|
CN101291658B
(zh)
|
2005-08-31 |
2014-04-16 |
阿布拉科斯生物科学有限公司 |
用于制备稳定性增加的水难溶性药物的组合物和方法
|
|
LT3311805T
(lt)
|
2005-08-31 |
2020-04-27 |
Abraxis Bioscience, Llc |
Kompozicijos, apimančios silpnai vandenyje tirpius farmacinius agentus ir priešmikrobinius agentus
|
|
EP1951906B1
(en)
|
2005-11-10 |
2010-12-22 |
Bristol-Myers Squibb Pharma Company |
Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers
|
|
WO2007059116A2
(en)
|
2005-11-14 |
2007-05-24 |
Abraxis Bioscience, Inc. |
Geldanamycin derivatives and pharmaceutical compositions thereof
|
|
WO2007107305A2
(en)
|
2006-03-22 |
2007-09-27 |
Medigene Ag |
Treatment of triple receptor negative breast cancer
|
|
CN101568332A
(zh)
|
2006-08-31 |
2009-10-28 |
阿布拉科斯生物科学公司 |
抑制血管生成及治疗血管生成相关疾病的方法
|
|
US20080280987A1
(en)
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
US20100112077A1
(en)
|
2006-11-06 |
2010-05-06 |
Abraxis Bioscience, Llc |
Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
|
|
SI2117520T1
(sl)
|
2006-12-14 |
2019-01-31 |
Abraxis Bioscience, Llc |
Zdravljenje raka dojk glede na status hormonskih receptorjev z nano delci, ki zajemajo taksan
|
|
CA3201293A1
(en)
|
2007-03-07 |
2008-09-12 |
Abraxis Bioscience, Llc |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
WO2008128169A1
(en)
*
|
2007-04-13 |
2008-10-23 |
Abraxis Bioscience, Inc. |
Sparc and methods of use thereof
|
|
CA2686736A1
(en)
|
2007-05-03 |
2008-11-13 |
Abraxis Bioscience, Llc |
Nanoparticle compositions comprising rapamycin for treating pulmonary hypertension
|
|
AU2008260447B2
(en)
|
2007-06-01 |
2013-10-10 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
|
MX2009013646A
(es)
|
2007-06-15 |
2010-03-30 |
Univ South Florida |
Metodos de diagnostico y tratamiento del cancer.
|
|
WO2009009587A2
(en)
|
2007-07-09 |
2009-01-15 |
Board Of Regents Of The University Of Nebraska |
Apoptosis-modulating protein therapy for proliferative disorders and nanoparticles containing the same
|
|
KR20150136137A
(ko)
|
2008-04-10 |
2015-12-04 |
아브락시스 바이오사이언스, 엘엘씨 |
소수성 탁산 유도체의 조성물 및 그의 용도
|
|
AU2009234127B2
(en)
|
2008-04-10 |
2015-04-30 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
US20120128732A1
(en)
|
2008-12-11 |
2012-05-24 |
Vuong Trieu |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
US20120039805A1
(en)
|
2009-02-20 |
2012-02-16 |
Pangea Biosciences, Inc. |
Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
|
|
BRPI1008955A2
(pt)
|
2009-03-13 |
2015-09-01 |
Abraxis Bioscience Llc |
Terapia de combinação com derivados de tiocolchicina.
|
|
CN102458112A
(zh)
|
2009-04-10 |
2012-05-16 |
阿布拉科斯生物科学有限公司 |
纳米颗粒制剂及其用途
|
|
ES2764100T3
(es)
|
2009-04-15 |
2020-06-02 |
Abraxis Bioscience Llc |
Composiciones de nanopartículas exentas de priones y métodos
|
|
DK2470173T3
(en)
|
2009-08-25 |
2016-06-06 |
Abraxis Bioscience Llc |
Combination therapy of nanoparticle composition of the taxane and the hedgehog inhibitors
|
|
EP2552438B1
(en)
|
2010-03-26 |
2016-05-11 |
Abraxis BioScience, LLC |
Methods of treatment of hepatocellular carcinoma
|
|
BR112012024442A2
(pt)
*
|
2010-03-29 |
2017-03-21 |
Abraxis Bioscience Llc |
métodos de tratamento de câncer
|
|
CA2794147A1
(en)
|
2010-03-29 |
2011-10-06 |
Abraxis Bioscience, Llc |
Use of a composition comprising nanoparticles comprising a taxane and an albumin to improve uptake of chemotherapeutics by tumors and for treating a cancer that is highly fibrotic and/or has a dense stroma
|
|
MX343671B
(es)
|
2010-06-02 |
2016-11-16 |
Abraxis Bioscience Llc * |
Metodos de tratamiento de cancer de vejiga.
|
|
RU2576609C2
(ru)
|
2010-06-04 |
2016-03-10 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Способы лечение рака поджелудочной железы
|
|
EP3056201A1
(en)
|
2010-06-07 |
2016-08-17 |
Abraxis BioScience, LLC |
Combination therapy methods for treating proliferative diseases
|
|
CA2834040C
(en)
|
2011-04-28 |
2020-01-14 |
Abraxis Bioscience, Llc |
Intravascular delivery of nanoparticle compositions and uses thereof
|
|
HUE045661T2
(hu)
|
2011-12-14 |
2020-01-28 |
Abraxis Bioscience Llc |
Polimer segédanyagok alkalmazása részecskék liofilizálásához vagy fagyasztásához
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US20140186447A1
(en)
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
US20140199405A1
(en)
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on mutation status of k-ras
|
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
US20140199404A1
(en)
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on level of a nucleoside transporter
|
|
NZ630239A
(en)
|
2013-02-11 |
2017-08-25 |
Abraxis Bioscience Llc |
Methods of treating melanoma
|
|
EP2968254B1
(en)
|
2013-03-12 |
2020-04-22 |
Abraxis BioScience, LLC |
Methods of treating lung cancer
|
|
EP2968253A4
(en)
|
2013-03-13 |
2016-11-02 |
Abraxis Bioscience Llc |
METHOD FOR TREATING PEDIATRIC SOLID TUMORS
|
|
EP2968191B1
(en)
|
2013-03-14 |
2021-06-16 |
Abraxis BioScience, LLC |
Methods of treating bladder cancer
|